7-year Follow-Up Outcomes after Stereotactic Ablation Radiotherapy for Stage I NSCLC: Results of a Phase Π Clinical Trial

BACKGROUND: We evaluated the efficacy, pattern of failure, and toxicity of stereotactic ablative radiotherapy (SABR) for medically inoperable clinical stage I non-small cell lung cancer (NSCLC) in a prospective clinical trial with 7 years follow-up. METHODS: Eligible patients with histologically con...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer
Päätekijät: Sun, Bing, Brooks, Eric D., Komaki, Ritsuko, Liao, Zhongxing, Jeter, Melenda, McAleer, Mary, Allen, Pamela K., Balter, Peter A., Welsh, James D., O’Reilly, Michael, Gomez, Daniel, Hahn, Stephen. M., Roth, Jack A., Mehran, Reza J., Heymach, John V., Chang, Joe Y.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5544582/
https://ncbi.nlm.nih.gov/pubmed/28346656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30693
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia